Orexin/hypocretin role in reward: Implications for opioid and other addictions

British Journal of Pharmacology

Volumn 172, Issue 2, 2015, Pages 334-348

  Baimel, Corey ^a,b   Bartlett, Selena E ^c   Chiou, Lih Chu ^d   Lawrence, Andrew J ^e   Muschamp, John W ^f   Patkar, Omkar ^c   Tung, Li Wei ^d   Borgland, Stephanie L ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

addiction; dopamine; dynorphin; hypocretin; morphine; orexin; VTA

Indexed keywords

ALCOHOL; OPIATE; OREXIN; OREXIN 1 RECEPTOR; OREXIN 2 RECEPTOR; PROTEIN FOS; DYNORPHIN; NEUROPEPTIDE; OREXIN RECEPTOR; SIGNAL PEPTIDE;

AMYGDALOID NUCLEUS; BOLD SIGNAL; CELL ACTIVATION; DRUG SEEKING BEHAVIOR; HUMAN; HYPOTHALAMUS; INTRACELLULAR SIGNALING; NERVE CELL; NERVE CELL PLASTICITY; NERVE PROJECTION; NONHUMAN; OPIATE ADDICTION; PREFRONTAL CORTEX; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN TARGETING; RELAPSE; REVIEW; REWARD; STRESS; VENTRAL TEGMENTUM; WITHDRAWAL SYNDROME; ADDICTION; ANIMAL; METABOLISM;

ANIMALS; DYNORPHINS; ETHANOL; HUMANS; HYPOTHALAMUS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEUROPEPTIDES; OREXIN RECEPTORS; OREXINS; REWARD; SUBSTANCE-RELATED DISORDERS; VENTRAL TEGMENTAL AREA;

EID: 84920198139     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12639     Document Type: Review

References (170)

1. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013a). The Concise Guide to PHARMACOLOGY 2013/14: Transporters. Br J Pharmacol 170, 1706-1796.
2. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Catterall WA, et al. (2013b). The Concise Guide to PHARMACOLOGY 2013/14: Ligand-Gated Ion Channels. Br J Pharmacol 170: 1582-1606.
3. Adamantidis A, de Lecea L, (2008). The hypocretins as sensors for metabolism and arousal. J Physiol 587: 33-40.
4. Argilli E, Sibley DR, Malenka RC, England PM, Bonci A, (2008). Mechanism and time course of cocaine-induced long-term potentiation in the ventral tegmental area. J Neurosci 28: 9092-9100.
5. Azizi H, Mirnajafi-Zadeh J, Rohampour K, Semnanian S, (2010). Antagonism of orexin type 1 receptors in the locus coeruleus attenuates signs of naloxone-precipitated morphine withdrawal in rats. Neurosci Lett 482: 255-259.
6. Balcita-Pedicino JJ, Sesack SR, (2007). Orexin axons in the rat ventral tegmental area synapse infrequently onto dopamine and gamma-aminobutyric acid neurons. J Comp Neurol 503: 668-684.
7. Bals-Kubik R, Ableitner A, Herz A, Shippenberg TS, (1993). Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. J Pharmacol Exp Ther 264: 489-495.
8. Bisetti A, Cvetkovic V, Serafin M, Bayer L, Machard D, Jones BE, et al. (2006). Excitatory action of hypocretin/orexin on neurons of the central medial amygdala. Neuroscience 142: 999-1004.
9. Borgland SL, Malenka RC, Bonci A, (2004). Acute and chronic cocaine-induced potentiation of synaptic strength in the ventral tegmental area: electrophysiological and behavioral correlates in individual rats. J Neurosci 24: 7482-7490.
10. Borgland SL, Taha SA, Sarti F, Fields HL, Bonci A, (2006). Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 49: 589-601.
11. Borgland SL, Storm E, Bonci A, (2008). Orexin B/hypocretin 2 increases glutamatergic transmission to ventral tegmental area neurons. Eur J Neurosci 28: 1545-1556.
12. Borgland SL, Chang SJ, Bowers MS, Thompson JL, Vittoz N, Floresco SB, et al. (2009). Orexin A/hypocretin-1 selectively promotes motivation for positive reinforcers. J Neurosci 29: 11215-11225.
13. Boutrel B, Kenny PJ, Specio SE, Martin-Fardon R, Markou A, Koob GF, et al. (2005). Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc Natl Acad Sci U S A 102, 52: 19168-19173.
14. Brodie MS, Pesold C, Appel SB, (1999). Ethanol directly excites dopaminergic ventral tegmental area reward neurons. Alcohol Clin Exp Res 23: 1848-1852.
15. Brown RM, Lawrence AJ, (2013). Ascending orexinergic pathways and alcohol-seeking. Curr Opin Neurobiol 23: 467-472.
16. Brown RM, Khoo SYS, Lawrence AJ, (2013). Central orexin (hypocretin) 2 receptor antagonism reduces ethanol self-administration, but not cue-conditioned ethanol-seeking, in ethanol-preferring (iP) rats. Int J Neuropsychopharmacol 16: 2067-2079.
17. Burdakov D, Jensen LT, Alexopoulos H, Williams RH, Fearon IM, O'Kelly I, et al. (2006). Tandem-pore K+ channels mediate inhibition of orexin neurons by glucose. Neuron 50: 711-722.
18. Cador M, (1992). Limbic-striatal interactions in reward related processes: modulation by the dopaminergic system. Clin Neuropharmacol 15 (Suppl. 1 Pt A): 548A-549A.
19. Caffino L, Calabrese F, Giannotti G, Barbon A, Verheij MM, Racagni G, et al. (2013). Stress rapidly dysregulates the glutamatergic synapse in the prefrontal cortex of cocaine-withdrawn adolescent rats. Addict Biol. doi: 10.1111/adb.12089. [Epub ahead of print].
20. Caggiula AR, Hoebel BG, (1966). 'Copulation-reward site' in the posterior hypothalamus. Science 153 (741): 1284-1285.
21. Chavkin C, James IF, Goldstein A, (1982). Dynorphin is a specific endogenous ligand of the kappa opioid receptor. Science 215 (4531): 413-415.
22. Chen BT, Yau HJ, Hatch C, Kusumoto-Yoshida I, Cho SL, Hopf FW, et al. (2013a). Rescuing cocaine-induced prefrontal cortex hypoactivity prevents compulsive cocaine seeking. Nature 496 (7445): 359-362.
23. Chen X, Wang H, Lin Z, Li S, Li Y, Bergen HT, et al. (2013b). Orexins (hypocretins) contribute to fear and avoidance in rats exposed to a single episode of footshocks. Brain Struct Funct. doi: 10.1007/s00429-013-0626-3.
24. Chiou L-C, Tung L-W, Lee Y-S, Lu G-L, Lee H-J, Chagne L-Y, et al. (2013). Orexin-endocannabinoid signaling in stress-induced cocaine relapse, International Narcotic Research Conference, Cairns, Australia.
25. Chou TC, Lee CE, Lu J, Elmquist JK, Hara J, Willie JT, et al. (2001). Orexin (hypocretin) neurons contain dynorphin. J Neurosci 21: RC168.
26. Cippitelli A, Bilbao A, Hansson AC, del Arco I, Sommer W, Heilig M, et al. (2005). Cannabinoid CB1 receptor antagonism reduces conditioned reinstatement of ethanol-seeking behavior in rats. Eur J Neurosci 21: 2243-2251.
27. Cisler JM, Elton A, Kennedy AP, Young J, Smitherman S, Andrew James G, et al. (2013). Altered functional connectivity of the insular cortex across prefrontal networks in cocaine addiction. Psychiatry Res 213: 39-46.
28. Crocker A, España RA, Papadopoulou M, Saper CB, Faraco J, Sakurai T, et al. (2005). Concomitant loss of dynorphin, NARP, and orexin in narcolepsy. Neurology 65: 1184-1188.
29. Dayas CV, Buller KM, Day TA, (1999). Neuroendocrine responses to an emotional stressor: evidence for involvement of the medial but not the central amygdala. Eur J Neurosci 11: 2312-2322.
30. Dayas CV, McGranahan TM, Martin-Fardon R, Weiss F, (2008). Stimuli linked to ethanol availability activate hypothalamic CART and orexin neurons in a reinstatement model of relapse. Biol Psychiatry 63: 152-157.
31. De Vries TJ, Shaham Y, Homberg JR, Crombag H, Schuurman K, Dieben J, et al. (2001). A cannabinoid mechanism in relapse to cocaine seeking. Nat Med 7: 1151-1154.
32. De Vries TJ, de Vries W, Janssen MC, Schoffelmeer AN, (2005). Suppression of conditioned nicotine and sucrose seeking by the cannabinoid-1 receptor antagonist SR141716A. Behav Brain Res 161: 164-168.
33. Degenhardt L, Whiteford HA, Ferrari AJ, Baxter AJ, Charlson FJ, Hall WD, et al. (2013). Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010. Lancet 382: 1564-1574.
34. Di Chiara G, Imperato A, (1985). Ethanol preferentially stimulates dopamine release in the nucleus accumbens of freely moving rats. Eur J Pharmacol 115: 131-132.
35. Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz JC, et al. (1994). Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372 (6507): 686-691.
36. Di Sebastiano AR, Wilson-Perez HE, Lehman MN, Coolen LM, (2011). Lesions of orexin neurons block conditioned place preference for sexual behavior in male rats. Horm Behav 59: 1-8.
37. Dube MG, Kalra SP, Kalra PS, (1999). Food intake elicited by central administration of orexins/hypocretins: identification of hypothalamic sites of action. Brain Res 842: 473-477.
38. España RA, Plahn S, Berridge CW, (2002). Circadian-dependent and circadian-independent behavioral actions of hypocretin/orexin. Brain Res 943: 224-236.
39. España RA, Oleson EB, Locke JL, Brookshire BR, Roberts DC, Jones SR, (2010). The hypocretin-orexin system regulates cocaine self-administration via actions on the mesolimbic dopamine system. Eur J Neurosci 31: 336-348.
40. España RA, Melchior JR, Roberts DC, Jones SR, (2011). Hypocretin 1/orexin A in the ventral tegmental area enhances dopamine responses to cocaine and promotes cocaine self-administration. Psychopharmacology (Berl) 214: 415-426.
41. Estabrooke IV, McCarthy MT, Ko E, Chou TC, Chemelli RM, Yanagisawa M, et al. (2001). Fos expression in orexin neurons varies with behavioral state. J Neurosci 21: 1656-1662.
42. Fadel J, Deutch AY, (2002). Anatomical substrates of orexin-dopamine interactions: lateral hypothalamic projections to the ventral tegmental area. Neuroscience 111: 379-387.
43. Fattore L, Spano MS, Cossu G, Deiana S, Fratta W, (2003). Cannabinoid mechanism in reinstatement of heroin-seeking after a long period of abstinence in rats. Eur J Neurosci 17: 1723-1726.
44. Geisler S, Derst C, Veh RW, Zahm DS, (2007). Glutamatergic afferents of the ventral tegmental area in the rat. J Neurosci 27: 5730-5743.
45. George MS, Anton RF, Bloomer C, Teneback C, Drobes DJ, Lorberbaum JP, et al. (2001). Activation of prefrontal cortex and anterior thalamus in alcoholic subjects on exposure to alcohol-specific cues. Arch Gen Psychiatry 58: 345-352.
46. Georgescu D, Zachariou V, Barrot M, Mieda M, Willie JT, Eisch AJ, et al. (2003). Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal. J Neurosci 23: 3106-3111.
47. González JA, Jensen LT, Fugger L, Burdakov D, (2012). Convergent inputs from electrically and topographically distinct orexin cells to locus coeruleus and ventral tegmental area. Eur J Neurosci 35: 1426-1432.
48. Gozzi A, Turrini G, Piccoli L, Massagrande M, Amantini D, Antolini M, et al. (2011). Functional magentic resonance imaging reveals different neural substrates for the effects of orexin-1 and orexin-2 receptor antagonists. PLoS ONE 6: e16406.
49. Gozzi A, Lepore S, Vicentini E, Merlo-Pich E, Bifone A, (2013). Differential effect of orexin-1 and CRF-1 antagonism on stress circuits: a fMRI study in the rat with the pharmacological stressor yohimbine. Neuropsychopharmacology 38: 2120-2130.
50. Gray TS, Carney ME, Magnuson DJ, (1989). Direct projections from the central amygdaloid nucleus to the hypothalamic paraventricular nucleus: possible role in stress-induced adrenocorticotropin release. Neuroendocrinology 50: 433-446.
51. Groenewegen HJ, Berendse HW, Wolters JG, Lohman AH, (1990). The anatomical relationship of the prefrontal cortex with the striatopallidal system, the thalamus and the amygdala: evidence for a parallel organization. Prog Brain Res 85: 95-116, discussion 116-118.
52. Gulia KK, Mallick HN, Kumar VM, (2003). Orexin A (hypocretin-1) application at the medial preoptic area potentiates male sexual behavior in rats. Neuroscience 116: 921-923.
53. Harris GC, Aston-Jones G, (2006). Arousal and reward: a dichotomy in orexin function. Trends Neurosci 29: 571-577.
54. Harris GC, Wimmer M, Aston-Jones G, (2005). A role for lateral hypothalamic orexin neurons in reward seeking. Nature 437 (7058): 556-559.
55. Harris GC, Wimmer M, Randall-Thompson JF, Aston-Jones G, (2007). Lateral hypothalamic orexin neurons are critically involved in learning to associate an environment with morphine reward. Behav Brain Res 183: 43-51.
56. Haynes AC, Jackson B, Overend P, Buckingham RE, Wilson S, Tadayyon M, et al. (1999). Effects of single and chronic intracerebroventricular administration of the orexins on feeding in the rat. Peptides 20: 1099-1105.
57. Heath RG, (1963). Electrical self-stimulation of the brain in man. Am J Psychiatry 120: 571-577.
58. Herberg LJ, (1963). A hypothalamic mechanism causing seminal ejaculation. Nature 198: 219-220.
59. Hess WR, (1954) Diencephalon: Autonomic and Extrapyramidal Functions. Grune and Stratton: New York.
60. Ho YC, Lee HJ, Tung LW, Liao YY, Fu SY, Teng SF, et al. (2011). Activation of orexin 1 receptors in the periaqueductal gray of male rats leads to antinociception via retrograde endocannabinoid (2-arachidonoylglycerol)-induced disinhibition. J Neurosci 31: 14600-14610.
61. Hoebel BG, (1969). Feeding and self-stimulation. Ann N Y Acad Sci 157: 758-778.
62. Hoebel BG, (1976) Brain-stimulation reward and aversion in relation to behavior. In:, Wauquier A, Rolls ET, (eds). Brain Stimulation Reward. Elsevier: New York, pp. 335-372.
63. Hoebel BG, Teitelbaum P, (1962). Hypothalamic control of feeding and self-stimulation. Science 135: 375-377.
64. Hollander JA, Lu Q, Cameron MD, Kamenecka TM, Kenny PJ, (2008). Insular hypocretin transmission regulates nicotine reward. Proc Natl Acad Sci U S A 105: 19480-19485.
65. Hollander JA, Pham D, Fowler CD, Kenny PJ, (2012). Hypocretin-1 receptors regulate the reinforcing and reward-enhancing effects of cocaine: pharmacological and behavioral genetics evidence. Front Behav Neurosci 6: 47.
66. Johnson PL, Samuels BC, Fitz SD, Federici LM, Hammes N, Early MC, et al. (2012). Orexin 1 receptors are a novel target to modulate panic responses and the panic brain network. Physiol Behav 107: 733-742.
67. Jupp B, Krivdic B, Krstew E, Lawrence AJ, (2011a). The orexin receptor antagonist SB-334867 dissociates the motivational properties of alcohol and sucrose in rats. Brain Res 1391: 54-59.
68. Jupp B, Krstew E, Dezsi G, Lawrence AJ, (2011b). Discrete cue-conditioned ethanol-seeking after protracted abstinence: pattern of neural activation and involvement of orexin(1) receptors. Br J Pharmacol 162: 880-889.
69. Kalivas PW, Alesdatter JE, (1993). Involvement of N-methyl-D-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine. J Pharmacol Exp Ther 267: 486-495.
70. Kalivas PW, Churchill L, Klitenick MA, (1993) The circuitry mediating the motivational stimuli into adaptive motor responses. In:, Kalivas PW, Barnes CD, (eds). Limbic Motor Circuits and Neuropsychiatry. CRC Press: Boca Raton, FL, pp. 237-288.
71. Kano M, Ohno-Shosaku T, Hashimotodani Y, Uchigashima M, Watanabe M, (2009). Endocannabinoid-mediated control of synaptic transmission. Physiol Rev 89: 309-380.
72. Karnani MM, Apergis-Schoute J, Adamantidis A, Jensen LT, de Lecea L, Fugger L, et al. (2011). Activation of central orexin/hypocretin neurons by dietary amino acids. Neuron 72: 616-629.
73. Kauer JA, Malenka RC, (2007). Synaptic plasticity and addiction. Nat Rev Neurosci 8: 844-858.
74. Kim AK, Brown RM, Lawrence AJ, (2012). The role of orexins/hypocretins in alcohol use and abuse: an appetitive-reward relationship. Front Behav Neurosci 6: 78.
75. Knoll AT, Muschamp JW, Sillivan SE, Ferguson D, Dietz DM, Meloni EG, et al. (2011). Kappa opioid receptor signaling in the basolateral amygdala regulates conditioned fear and anxiety in rats. Biol Psychiatry 70: 425-433.
76. Koob GF, Bloom FE, (1988). Cellular and molecular mechanisms of drug dependence. Science 242 (4879): 715-723.
77. Koob GF, Le Moal M, (2008). Addiction and the brain antireward system. Annu Rev Psychol 59: 29-53.
78. Korotkova TM, Sergeeva OA, Eriksson KS, Haas HL, Brown RE, (2003). Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins. J Neurosci 23: 7-11.
79. Kotz CM, Teske JA, Levine JA, Wang C, (2002). Feeding and activity induced by orexin A in the lateral hypothalamus in rats. Regul Pept 104: 27-32.
80. Kukkonen JP, Leonard CS, (2014). Orexin/hypocretin receptor signalling cascades. Br J Pharmacol 171: 314-331.
81. Kunii K, Yamanaka A, Nambu T, Matsuzaki I, Goto K, Sakurai T, (1999). Orexins/hypocretins regulate drinking behaviour. Brain Res 842: 256-261.
82. Lammel S, Hetzel A, Hackel O, Jones I, Liss B, Roeper J, (2008). Unique properties of mesoprefrontal neurons within a dual mesocorticolimbic dopamine system. Neuron 57: 760-773.
83. Lammel S, Ion DI, Roeper J, Malenka RC, (2011). Projection-specific modulation of dopamine neuron synapses by aversive and rewarding stimuli. Neuron 70: 855-862.
84. Lammel S, Lim BK, Ran C, Huang KW, Betley MJ, Tye KM, et al. (2012). Input-specific control of reward and aversion in the ventral tegmental area. Nature 491: 212-217.
85. Land BB, Bruchas MR, Lemos JC, Xu M, Melief EJ, Chavkin C, (2008). The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system. J Neurosci 28: 407-414.
86. Laorden ML, Ferenczi S, Pintér-Kübler B, González-Martín LL, Lasheras MC, Kovács KJ, et al. (2012). Hypothalamic orexin-a neurons are involved in the response of the brain stress system to morphine withdrawal. PLoS ONE 7: e36871.
87. Lawrence AJ, Cowen MS, Yang HJ, Chen F, Oldfield B, (2006). The orexin system regulates alcohol-seeking in rats. Br J Pharmacol 148: 752-759.
88. de Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, et al. (1998). The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A 95: 322-327.
89. Li A, Hindmarch CCT, Nattie EE, Paton JFR, (2013). Antagonism of orexin receptors significantly lowers blood pressure in spontaneously hypertensive rats. J Physiolo 591: 4237-4248.
90. Li Y, van den Pol AN, (2006). Differential target-dependent actions of coexpressed inhibitory dynorphin and excitatory hypocretin/orexin neuropeptides. J Neurosci 26: 13037-13047.
91. Li Y, van den Pol AN, (2008). Mu-opioid receptor-mediated depression of the hypothalamic hypcrerin/orexin arousal system. J Neurosci 28: 2814-2819.
92. Lin L, Faraco J, Li R, Kadotani H, Rogers W, Lin XY, et al. (1999). The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98: 365-376.
93. Liu RJ, Aghajanian GK, (2008). Stress blunts serotonin- and hypocretin-evoked EPSCs in prefrontal cortex: role of corticosterone-mediated apical dendritic atrophy. Proc Natl Acad Sci U S A 105: 359-364.
94. Ludanyi A, Hu SS, Yamazaki M, Tanimura A, Piomelli D, Watanabe M, et al. (2011). Complementary synaptic distribution of enzymes responsible for synthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in the human hippocampus. Neuroscience 174: 50-63.
95. Lüscher C, Malenka RC, (2011). Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling. Neuron 69: 650-663.
96. Mahler SV, Smith RJ, Moorman DE, Sartor GC, Aston-Jones G, (2012). Multiple roles for orexin/hypocretin in addiction. Prog Brain Res 198: 79-121.
97. Mahler SV, Smith RJ, Aston-Jones G, (2013). Interactions between VTA orexin and glutamate in cue-induced reinstatement of cocaine seeking in rats. Psychopharmacology (Berl) 226: 687-698.
98. Mansour A, Fox CA, Burke S, Meng F, Thompson RC, Akil H, et al. (1994). Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J Comp Neurol 350: 412-438.
99. Margolis EB, Mitchell JM, Ishikawa J, Hjelmstad GO, Fields HL, (2008). Midbrain dopamine neurons: projection target determines action potential duration and dopamine D(2) receptor inhibition. J Neurosci 28: 8908-8913.
100. Margules DL, Olds J, (1962). Identical 'feeding' and 'rewarding' systems in the lateral hypothalamus of rats. Science 135: 374-375.
101. Matyas F, Urban GM, Watanabe M, Mackie K, Zimmer A, Freund TF, et al. (2008). Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area. Neuropharmacology 54: 95-107.
102. McFarland K, Davidge SB, Lapish CC, Kalivas PW, (2004). Limbic and motor circuitry underlying footshock-induced reinstatement of cocaine-seeking behavior. J Neurosci 24: 1551-1560.
103. McPherson CS, Featherby T, Krstew E, Lawrence AJ, (2007). Quantification of phosphorylated cAMP-response element-binding protein expression throughout the brain of amphetamine-sensitized rats: activation of hypothalamic orexin A-containing neurons. J Pharmacol Exp Ther 2323: 805-812.
104. Mileykovskiy BY, Kiyashchenko LI, Siegel JM, (2005). Behavioral correlates of activity in identified hypocretin/orexin neurons. Neuron 46: 787-798.
105. Mogenson GJ, Stevenson IAF, (1967). Drinking and self-stimulation with electrical stimulation of the lateral hypothalamus. Physiol Behav 1: 251-254.
106. Moorman DE, Aston-Jones G, (2009). Orexin-1 receptor antagonism decreases ethanol consumption and preference selectively in high-ethanol-preferring Sprague-Dawley rats. Alcohol 43: 379-386.
107. Moorman DE, Aston-Jones G, (2010). Orexin/hypocretin modulates response of ventral tegmental dopamine neurons to prefrontal activation: diurnal influences. J Neurosci 30: 15585-15599.
108. Muschamp JW, Dominguez JM, Sato SM, Shen RY, Hull EM, (2007). A role for hypocretin (orexin) in male sexual behavior. J Neurosci 27: 2837-2845.
109. Muschamp JW, Hollander JA, Thompson JL, Onvani S, Hassinger LC, Kamenecka TM, et al. (2012). Opposing actions of hypocretin (orexin) and dynorphin co-transmission on motivated behavior. Program No. 498.20.2012 Neuroscience Meeting Planner. New Orleans, LA: Society for Neuroscience, 2012. Online.
110. Nakamura S, Tsumori T, Yokota S, Oka T, Yasui Y, (2009). Amygdaloid axons innervate melanin-concentrating hormone- and orexin-containing neurons in the mouse lateral hypothalamus. Brain Res 1278: 66-74.
111. Narita M, Nagumo Y, Hashimoto S, Narita M, Khotib J, Miyatake M, et al. (2006). Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine. J Neurosci 26: 398-405.
112. Narita M, Nagumo Y, Miyatake M, Ikegami D, Kurahashi K, Suzuki T, (2007). Implication of protein kinase C in the orexin-induced elevation of extracellular dopamine levels and its rewarding effect. Eur J Neurosci 25: 1537-1545.
113. Nishino S, (2011). Hypothalamus, hypocretins/orexin, and vigilance control. Handb Clin Neurol 99: 765-782.
114. Olds J, Milner P, (1954). Positive reinforcement produced by electrical stimulation of the septal area and other regions of the rat brain. J Comp Physiol Psychol 47: 419-427.
115. Overton P, Clark D, (1991). N-methyl-D-aspartate increases the excitability of nigrostriatal dopamine terminals. Eur J Pharmacol 201: 117-120.
116. Pasumarthi RK, Reznikov LR, Fadel J, (2006). Activation of orexin neurons by acute nicotine. Eur J Pharmacol 535: 172-176.
117. Pentkowski NS, Duke FD, Weber SM, Pockros LA, Teer AP, Hamilton EC, et al. (2010). Stimulation of medial prefrontal cortex serotonin 2C (5-HT2C) receptors attenuates cocaine-seeking behavior. Neuropsychopharmacology 35: 2037-2048.
118. Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG, et al. (1998). Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 18: 9996-10015.
119. Pfeiffer A, Brantl V, Herz A, Emrich HM, (1986). Psychotomimesis mediated by kappa opiate receptors. Science 233: 774-776.
120. Pietro N, Mashhoon Y, Heaney C, Yager L, Kantak K, (2008). Role of dopamine D1 receptors in the prefrontal dorsal agranular insular cortex in mediating cocaine self-administration in rats. Psychopharmacology (Berl) 200: 81-91.
121. Plaza-Zabala A, Martin-Garcia E, de Lecea L, Maldonado R, Berrendero F, (2010). Hypocretins regulate the anxiogenic-like effects of nicotine and induce reinstatement of nicotine-seeking behavior. J Neurosci 30: 2300-2310.
122. Plaza-Zabala A, Flores A, Maldonado R, Berrendero F, (2012). Hypocretin/orexin signaling in the hypothalamic paraventricular nucleus is essential for the expression of nicotine withdrawal. Biol Psychiatry 71: 214-223.
123. Quarta D, Valerio E, Hutcheson DM, Hedou G, Heidbreder C, (2009). The orexin-1 receptor antagonist SB-334867 reduces amphetamine-evoked dopamine outflow in the shell of the nucleus accumbens and decreases the expression of amphetamine sensitization. Neurochem Int 56: 11-15.
124. Rao Y, Mineur YS, Gan G, Wang AH, Liu ZW, Wu X, et al. (2013). Repeated in vivo exposure of cocaine induces long-lasting synaptic plasticity in hypocretin/orexin -producing neurons in the lateral hypothalamus in mice. J Physiolo 591: 1951-1966.
125. Richards JK, Simms JA, Steensland P, Taha SA, Borgland SL, Bonci A, et al. (2008). Inhibition of orexin-1/hypocretin-1 receptors inhibits yohimbine-induced reinstatement of ethanol and sucrose seeking in Long-Evans rats. Psychopharmacology (Berl) 199: 109-117.
126. Robinson TE, Berridge KC, (1993). The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 18: 247-291.
127. Rolls ET, Kelly PH, (1972). Neural basis of stimulus-bound locomotor activity in the rat. J Comp Physiol Psychol 81: 173-182.
128. Rosin DL, Weston MC, Sevigny CP, Stornetta RL, Guyenet PG, (2003). Hypothalamic orexin (hypocretin) neurons express vesicular glutamate transporters VGLUT1 or VGLUT2. J Comp Neurol 465: 593-603.
129. Saal D, Dong Y, Bonci A, Malenka RC, (2003). Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron 37: 577-582.
130. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, et al. (1998). Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92: 573-585.
131. Samson HH, Chappell A, (2003). Dopaminergic involvement in medial prefrontal cortex and core of the nucleus accumbens in the regulation of ethanol self-administration: a dual-site microinjection study in the rat. Physiol Behav 79: 581-590.
132. Sartor GC, Aston-Jones GS, (2012). A septal-hypothalamic pathway drives orexin neurons, which is necessary for conditioned cocaine preference. J Neurosci 32: 4623-4631.
133. Schmitt O, Usunoff KG, Lazarov NE, Itzev DE, Eipert P, Rolfs A, et al. (2012). Orexinergic innervation of the extended amygdala and basal ganglia in the rat. Brain Struct Funct 217: 233-256.
134. Schultz W, (2002). Getting formal with dopamine and reward. Neuron 36: 241-263.
135. Seamans JK, Gorelova N, Durstewitz D, Yang CR, (2001). Bidirectional dopamine modulation of GABAergic inhibition in prefrontal cortical pyramidal neurons. J Neurosci 21: 3628-3638.
136. Sesack SR, Carr DB, Omelchenko N, Pinto A, (2003). Anatomical substrates for glutamate-dopamine interactions: evidence for specificity of connections and extrasynaptic actions. Ann N Y Acad Sci 1003: 36-52.
137. Sharf R, Sarhan M, Dileone RJ, (2008). Orexin mediates the expression of precipitated morphine withdrawal and concurrent activation of the nucleus accumbens shell. Biol Psychiatry 64: 175-183.
138. Sharf R, Sarhan M, Dileone RJ, (2010). Role of orexin/hypocretin in dependence and addiction. Brain Res 1314: 130-138.
139. Shirayama Y, Ishida H, Iwata M, Hazama GI, Kawahara R, Duman RS, (2004). Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects. J Neurochem 90: 1258-1268.
140. Shoblock JR, Welty N, Aluisio L, Fraser I, Motley ST, Morton K, et al. (2011). Selective blockade of the orexin-2 receptor attenuates ethanol self-administration, place preference, and reinstatement. Psychopharmacology (Berl) 215: 191-203.
141. Shoji S, Simms D, McDaniel WC, Gallagher JP, (1997). Chronic cocaine enhances gamma-aminobutyric acid and glutamate release by altering presynaptic and not postsynaptic gamma-aminobutyric acid B receptors within the rat dorsolateral septal nucleus. J Pharmacol Exp Ther 280: 129-137.
142. Shoji S, Simms D, Yamada K, Gallagher JP, (1998). Cocaine administered in vitro to brain slices from rats treated with cocaine chronically in vivo results in a gamma-aminobutyric acid receptor-mediated hyperpolarization recorded from the dorsolateral septum. J Pharmacol Exp Ther 286: 509-518.
143. Smith RJ, See RE, Aston-Jones G, (2009). Orexin/hypocretin signaling at the orexin 1 receptor regulates cue-elicited cocaine-seeking. Eur J Neurosci 30: 493-503.
144. Srinivasan S, Simms JA, Nielsen CK, Lieske SP, Bito-Onon JJ, Yi H, et al. (2012). The dual orexin/hypocretin receptor antagonist, almorexant, in the ventral tegmental area attenuates ethanol self-administration. PLoS ONE 7: e44726.
145. Steinberg EE, Keiflin R, Boivin JR, Witten IB, Deisseroth K, Janak PH, (2013). A causal link between prediction errors, dopamine neurons and learning. Nat Neurosci 16: 966-973.
146. Steiner MA, Lecourt H, Jenck F, (2012). The brain orexin system and almorexant in fear-conditioned startle reactions in the rat. Psychopharmacology (Berl) 223: 465-475.
147. Suaud-Chagny MF, Chergui K, Chouvet G, Gonon F, (1992). Relationship between dopamine release in the rat nucleus accumbens and the discharge activity of dopaminergic neurons during local in vivo application of amino acids in the ventral tegmental area. Neuroscience 49: 63-72.
148. Tong ZY, Overton PG, Clark D, (1996). Antagonism of NMDA receptors but not AMPA/kainate receptors blocks bursting in dopaminergic neurons induced by electrical stimulation of the prefrontal cortex. J Neural Transm 103: 889-904.
149. Trivedi P, Yu H, MacNeil DJ, Van der Ploeg LH, Guan XM, (1998). Distribution of orexin receptor mRNA in the rat brain. FEBS Lett 438: 71-75.
150. Tsai HC, Zhang F, Adamantidis A, Stuber GD, Bonci A, de Lecea L, et al. (2009). Phasic firing in dopaminergic neurons is sufficient for behavioral conditioning. Science 324 (5930): 1080-1084.
151. Tung LW, Chiou LC, (2012) Orexin A increases dopaminergic activity via OX1 receptor-mediated endocannabinoid retrograde disinhibition in the ventral tegmental area- A novel addiction mechanism. Neuroscience 2012, Prog. No. 73.10, New Orleans, LA, USA.
152. Ungless MA, Whistler JL, Malenka RC, Bonci A, (2001). Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature 411: 583-587.
153. Valenstein ES, (1973) History of brain stimulation: investigations into the physiology of motivation. In:, Valenstein ES, (ed.). Brain Stimulation and Motivation. Scott, Foresman and Company: Glenview, IL, pp. 1-44.
154. Valenstein ES, Cox VC, Kakolewski JW, (1968). Modification of motivated behavior elicited by electrical stimulation of the hypothalamus. Science 159 (819): 1119-1121.
155. Valenstein ES, Cox VC, Kakolewski JW, (1970). Reexamination of the role of the hypothalamus in motivation. Psychol Rev 77: 16-31.
156. Van't Veer A, Carlezon WA Jr, (2013). Role of kappa-opioid receptors in stress and anxiety-related behavior. Psychopharmacology (Berl) 229: 435-452.
157. Vaughan E, Fisher AE, (1962). Male sexual behavior induced by intracranial electrical stimulation. Science 137: 758-760.
158. Vittoz NM, Berridge CW, (2006). Hypocretin/orexin selectively increases dopamine efflux within the prefrontal cortex: involvement of the ventral tegmental area. Neuropsychopharmacology 31: 384-395.
159. Vittoz NM, Schmeichel B, Berridge CW, (2008). Hypocretin /orexin preferentially activates caudomedial ventral tegmental area dopamine neurons. Eur J Neurosci 28: 1629-1640.
160. Walsh SL, Strain EC, Abreu ME, Bigelow GE, (2001). Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans. Psychopharmacology (Berl) 157: 151-162.
161. Wang B, You ZB, Wise RA, (2009). Reinstatement of cocaine seeking by hypocretin (orexin) in the ventral tegmental area: independence from the local corticotropin-releasing factor network. Biol Psychiatry 65: 857-862.
162. Willie JT, Chemelli RM, Sinton CM, Tokita S, Williams SC, Kisanuki YY, et al. (2003). Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes. Neuron 38: 715-730.
163. Winsky-Sommerer R, Yamanaka A, Diano S, Borok E, Roberts AJ, Sakurai T, et al. (2004). Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response. J Neurosci 24: 11439-11448.
164. Wise RA, Rompre PP, (1989). Brain dopamine and reward. Annu Rev Psychol 40: 191-225.
165. Yan J, He C, Xia JX, Zhang D, Hu ZA, (2012). Orexin-A excites pyramidal neurons in layer 2/3 of the rat prefrontal cortex. Neurosci Lett 520: 92-97.
166. Yang CR, Seamans JK, Gorelova N, (1999). Developing a neuronal model for the pathophysiology of schizophrenia based on the nature of electrophysiological actions of dopamine in the prefrontal cortex. Neuropsychopharmacology 21: 161-194.
167. Yeoh JW, James MH, Jobling P, Bains JS, Graham BA, Dayas CV, (2012). Cocaine potentiates excitatory drive in the perifornical/lateral hypothalamus. J Physiol 590: 3677-3689.
168. Yoshida K, McCormack S, España RA, Crocker A, Scammell TE, (2006). Afferents to the orexin neurons of the rat brain. J Comp Neurol 494: 845-861.
169. Zhou Y, Bendor J, Hofmann L, Randesi M, Ho A, Kreek MJ, (2006). Mu opioid receptor and orexin/hypocretin mRNA levels in the lateral hypothalamus and striatum are enhanced by morphine withdrawal. J Endocrinol 191: 137-145.
170. Zhou Y, Cui CL, Schlussman SD, Choi JC, Ho A, Han JS, et al. (2008). Effects of cocaine place conditioning, chronic escalating-dose 'binge' pattern cocaine administration and acute withdrawal on orexin/hypocretin and preprodynorphin gene expressions in lateral hypothalamus of Fischer and Sprague-Dawley rats. Neuroscience 153: 1225-1234.